Verona Pharma (VRNA) News Today $74.73 +2.15 (+2.96%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VRNA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Verona Pharma Announces June 2025 Investor Conference ParticipationMay 21 at 6:00 AM | globenewswire.comVerona Pharma plc (NASDAQ:VRNA) Shares Bought by Lazard Asset Management LLCLazard Asset Management LLC grew its holdings in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 36.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 34,503 shares of the company's stock after purchasing an additional 9,267 shares durMay 21 at 4:34 AM | marketbeat.comPoint72 Asset Management L.P. Buys New Position in Verona Pharma plc (NASDAQ:VRNA)Point72 Asset Management L.P. bought a new stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 711,007 shares of the company'sMay 19 at 5:53 AM | marketbeat.com1,821,019 Shares in Verona Pharma plc (NASDAQ:VRNA) Acquired by RTW Investments LPRTW Investments LP purchased a new position in Verona Pharma plc (NASDAQ:VRNA - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,821,019 shares of the company's stock, valued at approximately $84,568,000. VMay 18 at 6:54 AM | marketbeat.com39,369 Shares in Verona Pharma plc (NASDAQ:VRNA) Acquired by Point72 Europe London LLPPoint72 Europe London LLP bought a new position in Verona Pharma plc (NASDAQ:VRNA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 39,369 shares of the company's stock, valued at approximately $1,828,000.May 18 at 6:15 AM | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Receives Consensus Rating of "Buy" from AnalystsShares of Verona Pharma plc (NASDAQ:VRNA - Get Free Report) have been assigned a consensus rating of "Buy" from the nine research firms that are presently covering the stock, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned aMay 18 at 1:57 AM | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Stake Lifted by Parkman Healthcare Partners LLCParkman Healthcare Partners LLC lifted its holdings in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 15.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 720,657 shares of the company's stock after acquiring an additionalMay 16, 2025 | marketbeat.comNicholas Investment Partners LP Invests $7.19 Million in Verona Pharma plc (NASDAQ:VRNA)Nicholas Investment Partners LP purchased a new position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 154,814 shares of the company's stock,May 16, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Receives Average Rating of "Buy" from BrokeragesMay 16, 2025 | americanbankingnews.comOctagon Capital Advisors LP Sells 1,263,936 Shares of Verona Pharma plc (NASDAQ:VRNA)Octagon Capital Advisors LP lessened its position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 68.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 571,264 shares of the company's stock after selling 1,263,936 shares during the quarter. VeroMay 15, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Shares Bought by Janus Henderson Group PLCJanus Henderson Group PLC grew its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 59.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,667,165 shares of the company's stock after puMay 15, 2025 | marketbeat.comRaymond James Financial Inc. Invests $225,000 in Verona Pharma plc (NASDAQ:VRNA)Raymond James Financial Inc. purchased a new position in Verona Pharma plc (NASDAQ:VRNA - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 4,855 shares of the company's stock, valued at approximately $225,000. Several other hedge funds anMay 15, 2025 | marketbeat.comFred Alger Management LLC Takes $1.34 Million Position in Verona Pharma plc (NASDAQ:VRNA)Fred Alger Management LLC acquired a new position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 28,945 shares of the company's stock, valuedMay 13, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Shares Acquired by Barclays PLCBarclays PLC lifted its position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 1,379.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,313 shares of the company's stock after buying an additional 4,954 sMay 13, 2025 | marketbeat.comFindell Capital Management LLC Makes New $8.36 Million Investment in Verona Pharma plc (NASDAQ:VRNA)Findell Capital Management LLC purchased a new position in Verona Pharma plc (NASDAQ:VRNA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 180,000 shares of the company's stock, valued at approximMay 11, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $5.89 Million Stock Position in Verona Pharma plc (NASDAQ:VRNA)The Manufacturers Life Insurance Company grew its stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 20.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 126,730 shares of the company's stock after aMay 10, 2025 | marketbeat.comDeep Track Capital LP Sells 2,330,025 Shares of Verona Pharma plc (NASDAQ:VRNA)Deep Track Capital LP reduced its stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 73.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 850,000 shares of the company's stockMay 9, 2025 | marketbeat.comDuquesne Family Office LLC Purchases 201,535 Shares of Verona Pharma plc (NASDAQ:VRNA)Duquesne Family Office LLC boosted its position in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 29.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 887,580 shares of the company's stock after purchasing an additional 20May 9, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Insider Sells $1,014,158.88 in StockMay 9, 2025 | insidertrades.comWhat Makes Verona Pharma plc (VRNA) a Good Investment?May 8, 2025 | insidermonkey.comWhat Makes Verona Pharma plc (VRNA) a Good Investment?May 8, 2025 | msn.comCaxton Associates LP Acquires New Position in Verona Pharma plc (NASDAQ:VRNA)Caxton Associates LP acquired a new stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 29,552 shares of the company's stocMay 8, 2025 | marketbeat.comBeverly Hills Private Wealth LLC Purchases Shares of 5,566 Verona Pharma plc (NASDAQ:VRNA)Beverly Hills Private Wealth LLC acquired a new position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 5,566 shares of the company's stock, valuMay 8, 2025 | marketbeat.comAxa S.A. Sells 74,142 Shares of Verona Pharma plc (NASDAQ:VRNA)Axa S.A. reduced its position in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 26.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 203,883 shares of the company's stock after selling 74,142 shares duringMay 8, 2025 | marketbeat.comVerona Pharma Presents Positive Phase 3 Analyses of Ohtuvayre® for COPD at ATS 2025May 7, 2025 | nasdaq.comVerona Pharma Presents Positive Phase 3 Analyses of Ohtuvayre® for COPD at ATS 2025May 7, 2025 | nasdaq.comBellevue Group AG Trims Holdings in Verona Pharma plc (NASDAQ:VRNA)Bellevue Group AG decreased its position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 53.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 568,955 shares of the company's stock after selling 651,104May 6, 2025 | marketbeat.comVerona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025May 6, 2025 | globenewswire.comSchonfeld Strategic Advisors LLC Increases Stock Holdings in Verona Pharma plc (NASDAQ:VRNA)Schonfeld Strategic Advisors LLC lifted its stake in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 288.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 79,400 shares of the company's stock after buying an additioMay 6, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Sees Large Decline in Short InterestVerona Pharma plc (NASDAQ:VRNA - Get Free Report) was the target of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 7,780,000 shares, a drop of 14.8% from the March 31st total of 9,130,000 shares. Based on an average daily trading volume, of 1,360,000 shares, the days-to-cover ratio is currently 5.7 days. Approximately 10.2% of the shares of the stock are short sold.May 5, 2025 | marketbeat.comVoya Investment Management LLC Has $2.77 Million Position in Verona Pharma plc (NASDAQ:VRNA)Voya Investment Management LLC decreased its holdings in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 19.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 59,660 shares of the company's stock after sellingMay 5, 2025 | marketbeat.comHC Wainwright Boosts Earnings Estimates for Verona PharmaVerona Pharma plc (NASDAQ:VRNA - Free Report) - Research analysts at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for Verona Pharma in a report released on Wednesday, April 30th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per sMay 4, 2025 | marketbeat.comQ2 EPS Estimates for Verona Pharma Cut by Roth CapitalVerona Pharma plc (NASDAQ:VRNA - Free Report) - Stock analysts at Roth Capital lowered their Q2 2025 earnings per share estimates for Verona Pharma in a research note issued to investors on Tuesday, April 29th. Roth Capital analyst B. Pachaiyappan now expects that the company will post earnings pMay 4, 2025 | marketbeat.comRenaissance Technologies LLC Buys Shares of 15,500 Verona Pharma plc (NASDAQ:VRNA)Renaissance Technologies LLC purchased a new position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 15,500 shares of the company's stock, valued atMay 4, 2025 | marketbeat.comRoth Capital Reduces Earnings Estimates for Verona PharmaVerona Pharma plc (NASDAQ:VRNA - Free Report) - Equities research analysts at Roth Capital reduced their Q1 2026 earnings per share estimates for shares of Verona Pharma in a report issued on Tuesday, April 29th. Roth Capital analyst B. Pachaiyappan now expects that the company will earn $0.68 peMay 3, 2025 | marketbeat.comQ4 EPS Estimates for Verona Pharma Decreased by AnalystVerona Pharma plc (NASDAQ:VRNA - Free Report) - Equities researchers at HC Wainwright reduced their Q4 2025 earnings estimates for shares of Verona Pharma in a research report issued on Wednesday, April 30th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings ofMay 3, 2025 | marketbeat.comRA Capital Management L.P. Lowers Stock Position in Verona Pharma plc (NASDAQ:VRNA)RA Capital Management L.P. decreased its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 64.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,766,830 shares of the company's stock after sellMay 3, 2025 | marketbeat.comFY2025 EPS Estimates for Verona Pharma Decreased by AnalystVerona Pharma plc (NASDAQ:VRNA - Free Report) - Equities research analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Verona Pharma in a research report issued on Wednesday, April 30th. Cantor Fitzgerald analyst O. Brayer now anticipates that the company will post earningsMay 3, 2025 | marketbeat.comAquatic Capital Management LLC Takes $965,000 Position in Verona Pharma plc (NASDAQ:VRNA)Aquatic Capital Management LLC acquired a new position in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 20,787 shares of the company's stock, valued at approximately $965,000. Other iMay 3, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Given New $85.00 Price Target at HC WainwrightHC Wainwright raised their price objective on Verona Pharma from $75.00 to $85.00 and gave the company a "buy" rating in a report on Wednesday.May 2, 2025 | marketbeat.comSamsara BioCapital LLC Cuts Stock Holdings in Verona Pharma plc (NASDAQ:VRNA)Samsara BioCapital LLC lessened its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 50.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 97,625 shares of the company's stock after selling 97,600May 2, 2025 | marketbeat.comVerona Pharma (NASDAQ:VRNA) Reaches New 52-Week High - Still a Buy?Verona Pharma (NASDAQ:VRNA) Sets New 52-Week High - Here's What HappenedMay 2, 2025 | marketbeat.comVerona Pharma plc (NASDAQ:VRNA) Director Vikas Sinha Sells 20,000 SharesMay 2, 2025 | insidertrades.comVerona Pharma (NASDAQ:VRNA) Shares Gap Up - Here's WhyVerona Pharma (NASDAQ:VRNA) Shares Gap Up - What's Next?May 1, 2025 | marketbeat.comSilencing The Doubters: Verona Pharma Could Be Sitting On A BlockbusterMay 1, 2025 | seekingalpha.comDarwin Global Management Ltd. Invests $37.64 Million in Verona Pharma plc (NASDAQ:VRNA)Darwin Global Management Ltd. bought a new stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 810,449 shares of the company's stock, valued aMay 1, 2025 | marketbeat.com18,050 Shares in Verona Pharma plc (NASDAQ:VRNA) Purchased by AdvisorShares Investments LLCAdvisorShares Investments LLC purchased a new stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 18,050 shares of the company's stock, valued at approximately $838,000. Other hedge funds have also recentMay 1, 2025 | marketbeat.comAnalysts Are Betting On Verona Pharma plc (NASDAQ:VRNA) With A Big Upgrade This WeekMay 1, 2025 | finance.yahoo.comMarshall Wace LLP Raises Holdings in Verona Pharma plc (NASDAQ:VRNA)Marshall Wace LLP lifted its stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 123.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 28,617 shares of the company's stock after buying an additional 15,805 shareMay 1, 2025 | marketbeat.comVerona Pharma sees Ohtuvayre sales doubling in Q1 2025, projects expanded sales team by Q3April 30, 2025 | msn.com Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address VRNA Media Mentions By Week VRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRNA News Sentiment▼1.500.65▲Average Medical News Sentiment VRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRNA Articles This Week▼117▲VRNA Articles Average Week Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNTX News ONC News TEVA News SMMT News ITCI News GMAB News RDY News VTRS News MRNA News ASND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRNA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRNA Stock Free VRNA Stock Alerts